Argenica Therapeutics Completes phase one clinical trial dosing of ARG-007
Argenica Therapeutics (AGN) completes the dosing stage of a phase one clinical trial of...
Argenica Therapeutics Receives approval to commence final ARG-007 dosing
Argenica Therapeutics (AGN) receives approval to progress to the fourth and final cohort dosing of...
Argenica Therapeutics Raises $5.5m for clinical trials
Pharmaceutical company Argenica Therapeutics (AGN) receives binding commitments to raise $5.5 million via a placement
The funds...
